Skip to main content
Pharming Group N.V. (AMS:PHARM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
0.9815
+0.0145 (1.50%)
Jun 16, 2025, 5:35 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Recombinant Human C1 Esterase Inhibitor
226.91M
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human C1 Esterase Inhibitor Growth
15.98%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
221.17M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
16.17%
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of World
5.74M
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
-
Log In
Log In
Log In
Log In
Upgrade